Welcome to our dedicated page for Zentek news (Ticker: ZTEK), a resource for investors and traders seeking the latest updates and insights on Zentek stock.
Zentek Ltd. (ZTEK) generates news across several advanced technology domains, reflecting its role as an intellectual property development and commercialization company. Its disclosures highlight activity in graphene-based coatings, critical mineral development, aptamer-based healthcare technologies and fire-retardant materials, giving investors and observers multiple streams of company-specific updates.
A major news theme is Zentek’s work through its wholly owned subsidiary Albany Graphite Corp. on the Albany Graphite Project in Ontario. Recent releases describe ultra-high purity Albany graphite reaching five-nines carbon purity with an Equivalent Boron Concentration below thresholds generally referenced for nuclear applications, as well as additional nuclear suitability testing and independent verification using near-net-shaped graphite bricks. Separate announcements cover lithium-ion battery suitability testing, where spheroidized Albany graphite has shown near-theoretical anode performance under industry-standard conditions.
Another recurring topic is Zentek’s ZenGUARD™ platform for surgical masks and HVAC air filters, including corporate updates on testing under the Government of Canada’s Innovative Solutions Canada program and efforts to advance ZenGUARD™ Enhanced Air Filters in Canada and international markets. News items also address the company’s development of a Graphite Gel-Based Fire-Retardant product and an exclusive licensing arrangement with Altek Advanced Materials Inc. for commercialization in the United States.
Healthcare-focused news includes progress on multivalent aptamer countermeasures against influenza through Triera Biosciences and McMaster University, supported by a federal testing contract. Corporate governance and capital markets developments, such as CEO transitions, board appointments, annual meeting voting results and tax reassessment matters, are reported through regular press releases and associated Form 6-K filings. Readers following ZTEK news can expect updates on technology milestones, regulatory and testing programs, strategic partnerships and key corporate decisions.
Zentek (NASDAQ: ZTEK) subsidiary Albany Graphite executed an agreement with AETC to produce certified 4N, 4N+ and 5N+ graphite samples and deliver process engineering inputs for Micon's PEA.
AETC will supply Certificates of Analysis for samples (initial 1.5 kg per grade in May 2026; full CoAs by July 2026) and deliver a conceptual, multi‑phase purification plant design sized to 30,000 TPA, with engineering deliverables due June 2026 to align with the PEA timeline.
Zentek (NASDAQ: ZTEK) subsidiary Albany Graphite engaged AppEco to produce an independent market research and economic analysis for the Albany Graphite Project near Hearst, Ontario.
Deliverables include a grade-specific price deck, 5‑ and 10‑year forecasts, North American/allied demand quantification, supply positioning versus Western pipelines, and valuation of 18 recoverable critical minerals from FBR scrubber exhaust. Bench-scale production of 5N+ graphite (99.9992 wt.% Cg) using a chlorine-free FBR process is cited as central to the study feeding into a PEA due this summer.
Triera Biosciences (ZTEK) completed an Innovative Solutions Canada program and has begun an Ontario Centres of Innovation Collaborate 2 Commercialize agreement to advance its aptamer platform toward seasonal influenza candidates. The OCI C2C project budget is approximately $300,000 with matched cash contributions from OCI and Zentek.
Triera selected an H5N1-binding aptamer in ~7 weeks and will apply multivalent aptamer engineering to H1N1, H3N2 and expanded strains, with workstreams including dose-finding, PK/PD modeling and initiation of GLP-style toxicology and immunogenicity studies.
Zentek (NASDAQ: ZTEK) subsidiary Albany Graphite engaged Micon to complete a new NI 43-101 Preliminary Economic Assessment (PEA) for the Albany Graphite Project near Hearst, Ontario, expected this summer (2026).
Micon will evaluate a tested 5N+ thermal purification route (99.9992% Cg from 86% flotation concentrate), update the Mineral Resource Estimate, produce PEA-level capex/opex estimates, and analyze economic sensitivities and environmental considerations.
Zentek (NASDAQ: ZTEK) engaged ICP Securities to provide automated market-making using its proprietary ICP Premium® algorithm, effective April 1, 2026. The agreement has an Initial Term of four months with automatic monthly renewals and a monthly fee of C$7,500 plus taxes. The engagement is subject to TSX Venture Exchange approval.
The arrangement includes no equity or performance-based pay, allows ICP and its clients to acquire securities, and aims to improve liquidity and quote quality for shareholders.
Triera Biosciences (NASDAQ:ZTEK) is launching contract research organization services for custom aptamer discovery, biosensor enablement, and ML classification support on March 25, 2026.
Built on an exclusive 20-year McMaster University license, Triera offers integrated SELEX aptamer development, biosensor integration, and optional ML signal classification targeting infectious disease and oncology diagnostics across North America and Europe.
Zentek (NASDAQ:ZTEK) won a favorable judgment in Ontario Superior Court on March 12, 2026, dismissing substantially all claims in companion litigation tied to the 2018 removal of founder Aubrey Eveleigh.
The Court denied monetary claims originally exceeding $6 million, refused cancellation of 4.5 million founder shares, and found relevant statements factually accurate.
Zentek (NASDAQ:ZTEK) provided a PDAC 2026 update covering government and First Nations engagement during the March 1-4 convention in Toronto. The company attended the TSX Canadian Mining Roundtable on March 2, held meetings with federal and provincial representatives and Invest Ontario, and advanced collaboration with Constance Lake First Nation for the Albany Graphite Project.
Zentek said discussions advanced Albany's positioning for critical-minerals funding frameworks and planning toward environmental baseline studies and a new Preliminary Economic Assessment.
Zentek (NASDAQ:ZTEK) initiated an 8–12 week pilot evaluation with Quality Filters to test integration of Zentek's proprietary air filtration media into Quality's commercial HVAC and industrial filter lines. The pilot will assess compatibility, manufacturing scalability, and real‑world performance as a step toward a potential long‑term supply or licensing arrangement.
The pilot supports Zentek's IP‑integration commercialization pathway and runs in parallel with U.S. regulatory evaluation and an existing royalty arrangement with Altek.
Zentek (NASDAQ:ZTEK) outlines government engagement and plans to advance the Albany Graphite Project toward a Pre-Feasibility Study (PFS). Key actions include commissioning a new Preliminary Economic Assessment this fiscal quarter, initiating second-year environmental baseline work, advancing FBR purification engineering, and pursuing non-dilutive federal and provincial funding.
Albany has laboratory-scale nuclear-grade results (99.9992% purity; 2.60 ppm boron) and is positioned to access programs such as Canada's $2-billion Strategic Resource Fund and Ontario's $500 million Critical Minerals Processing Fund.